Tesamorelin

HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies

(2011) Julian Falutz   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Endothelial function is impaired in HIV-infected patients with lipodystrophy

(2010) Mar Masiá et al.   ANTIVIRAL THERAPY

Cardiovascular complications of AIDS

(2010) John Lekakis et al.   Current Opinion in Critical Care

Pathogenesis and treatment of HIV lipohypertrophy

(2010) Vivien L Leung et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Effects of Tesamorelin, a Growth Hormone-Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

(2010) Julian Falutz et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Effects of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor Analog, in Human Immunodeficiency Virus-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of Two Multicenter, Double-Blind Placebo-Controlled Phase 3 Trials with Safety Extension Data

(2010) Julian Falutz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of a Growth Hormone-Releasing Hormone Analog on Endogenous GH Pulsatility and Insulin Sensitivity in Healthy Men

(2010) Takara L. Stanley et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer

(2010) Robert G. Maki   JOURNAL OF CLINICAL ONCOLOGY

Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and for visceral fat respectively than for subcutaneous fat in adolescent girls

(2010) Eray Savgan-Gurol et al.   Nutrition & Metabolism

Recombinant Human Growth Hormone

(2009) Stefano Benedini et al.   BIODRUGS

Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?

(2009) S. A. Porter et al.   DIABETES CARE

Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects

(2009) Niels Møller et al.   ENDOCRINE REVIEWS

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study

(2009) A. A. Mahabadi et al.   EUROPEAN HEART JOURNAL

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation

(2008) Julian Falutz et al.   AIDS

Severity of Lipodystrophy Is Associated with Decreased Health-Related Quality of Life

(2008) Giovanni Guaraldi et al.   AIDS PATIENT CARE AND STDS

HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease

(2008) John Lekakis et al.   CLINICAL SCIENCE

HIV lipodystrophy and its metabolic consequences: implications for clinical practice

(2008) Anthony S. Wierzbicki et al.   CURRENT MEDICAL RESEARCH AND OPINION

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV

(2008) JD Lundgren et al.   HIV MEDICINE

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

(2008) BG Gazzard et al.   HIV MEDICINE

The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men

(2008) David Wohl et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Low-Dose Physiological Growth Hormone in Patients With HIV and Abdominal Fat Accumulation

(2008) Janet Lo   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION